1. Covalent‐Allosteric Kinase Inhibitors1. Issue 35 (25th June 2015) Authors: Weisner, Jörn; Gontla, Rajesh; van der Westhuizen, Leandi; Oeck, Sebastian; Ketzer, Julia; Janning, Petra; Richters, André; Mühlenberg, Thomas; Fang, Zhizhou; Taher, Abu; Jendrossek, Verena; Pelly, Stephen C.; Bauer, Sebastian; van Otterlo, Willem A. L.; Rauh, Daniel Journal: Angewandte Chemie international edition Issue: Volume 54:Issue 35(2015) Page Start: 10313 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. HER2 mediates clinical resistance to the KRASG12C inhibitor sotorasib, which is overcome by co-targeting SHP2. (December 2021) Authors: Ho, Cassandra S.L.; Tüns, Alicia I.; Schildhaus, Hans-Ulrich; Wiesweg, Marcel; Grüner, Barbara M.; Hegedus, Balazs; Schuler, Martin; Schramm, Alexander; Oeck, Sebastian Journal: European journal of cancer Issue: Volume 159(2021) Page Start: 16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Kovalent‐allosterische Kinase‐Inhibitoren1. (25th June 2015) Authors: Weisner, Jörn; Gontla, Rajesh; van der Westhuizen, Leandi; Oeck, Sebastian; Ketzer, Julia; Janning, Petra; Richters, André; Mühlenberg, Thomas; Fang, Zhizhou; Taher, Abu; Jendrossek, Verena; Pelly, Stephen C.; Bauer, Sebastian; van Otterlo, Willem A. L.; Rauh, Daniel Journal: Angewandte Chemie Issue: Volume 127:Number 35(2015) Page Start: 10452 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗